Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

DermTech

10 Disclosed Funding Rounds $116,160,639

0 Participating Investments


Health Care, Genetics, Biotechnology, Beauty, Health Diagnostics

DermTech develops and commercializes qPCR assays for skin samples using adhesive tape biopsy methods.

La Jolla, California, United States, North America (US)

Organizations in La Jolla in Health Care,
Organizations in La Jolla in Genetics,
Organizations in La Jolla in Biotechnology,
Organizations in La Jolla in Beauty,
Organizations in La Jolla in Health Diagnostics,
Organizations in California in Health Care,
Organizations in California in Genetics,
Organizations in California in Biotechnology,
Organizations in California in Beauty,
Organizations in California in Health Diagnostics,
Organizations in United States in Health Care,
Organizations in United States in Genetics,
Organizations in United States in Biotechnology,
Organizations in United States in Beauty,
Organizations in United States in Health Diagnostics,
Organizations in North America in Health Care,
Organizations in North America in Genetics,
Organizations in North America in Biotechnology,
Organizations in North America in Beauty,
Organizations in North America in Health Diagnostics

Investors in La Jolla in Health Care,
Investors in La Jolla in Genetics,
Investors in La Jolla in Biotechnology,
Investors in La Jolla in Beauty,
Investors in La Jolla in Health Diagnostics,
Investors in California in Health Care,
Investors in California in Genetics,
Investors in California in Biotechnology,
Investors in California in Beauty,
Investors in California in Health Diagnostics,
Investors in United States in Health Care,
Investors in United States in Genetics,
Investors in United States in Biotechnology,
Investors in United States in Beauty,
Investors in United States in Health Diagnostics,
Investors in North America in Health Care,
Investors in North America in Genetics,
Investors in North America in Biotechnology,
Investors in North America in Beauty,
Investors in North America in Health Diagnostics

Greater San Diego Area (0 Investors) (0 Startups), West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups)

Founded date 01, 1996

Founders John Dobak

Operating Status Active

Funding Stage M&A

Last Funding Type Post-IPO Equity

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego. The Company will initially offer an assay for pigmented skin lesions sampled using an adhesive tape collection method. The Company has identified gene targets differentially expressed in melanoma samples (British Journal of Dermatology, April 2011). This assay can assess RNA expression consistent with melanoma with very high sensitivity (>95%) and specificity (>70%).

Date Round Raised Lead
March, 02, 2020 Post-IPO Equity $65,000,000 -------
August, 01, 2019 Post-IPO Equity $4,000,000 -------
November, 01, 2017 Series C $10,000,000 -------
October, 21, 2016 Venture - Series Unknown $2,065,999 -------
November, 13, 2015 Venture - Series Unknown $4,314,872 -------
April, 14, 2015 Debt Financing $2,441,068 -------
August, 20, 2013 Series B $5,600,000 -------
April, 10, 2012 Venture - Series Unknown $11,580,000 -------
March, 24, 2008 Venture - Series Unknown $11,158,700 -------
June, 01, 1998 Venture - Series Unknown Undisclosed -------

DermTech Investors (2)

Investor Lead? Round Participating Raise Date Partners
HLM Venture Partners No Post-IPO Equity $4,000,000 August, 01, 2019 -------
Tech Coast Angels No Venture - Series Unknown Undisclosed June, 01, 1998 -------